Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
Egypt flag Egypt · Delayed Price · Currency is EGP
91.88
-0.01 (-0.01%)
At close: May 14, 2026

EGX:PHAR Ratios and Metrics

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
15,50713,0796,8295,4303,6214,155
Market Cap Growth
102.30%91.51%25.78%49.96%-12.86%-3.57%
Enterprise Value
23,17421,42614,5789,6305,3885,509
Last Close Price
91.8974.3641.4231.3622.7524.04
PE Ratio
10.339.076.236.605.638.52
Forward PE
10.627.037.035.925.776.23
PS Ratio
1.641.390.901.040.921.22
PB Ratio
2.372.001.471.271.121.40
P/TBV Ratio
2.502.111.481.281.121.40
P/OCF Ratio
14.1811.96-58.71-10.83
PEG Ratio
-1.021.021.021.021.02
EV/Sales Ratio
2.452.271.921.841.361.62
EV/EBITDA Ratio
7.868.749.077.337.106.35
EV/EBIT Ratio
8.179.159.677.958.147.09
Debt / Equity Ratio
1.351.351.981.150.880.59
Debt / EBITDA Ratio
3.593.595.733.743.762.03
Net Debt / Equity Ratio
1.131.131.701.000.730.49
Net Debt / EBITDA Ratio
3.013.014.933.233.131.67
Net Debt / FCF Ratio
-28.25-28.25-1.92-1.93-2.77-27.25
Asset Turnover
0.560.560.600.630.660.66
Inventory Turnover
1.421.421.461.361.211.08
Quick Ratio
0.390.390.360.650.540.67
Current Ratio
1.161.161.121.941.722.13
Return on Equity (ROE)
26.06%26.06%24.60%21.95%20.71%16.78%
Return on Assets (ROA)
8.70%8.70%7.43%9.04%6.89%9.46%
Return on Invested Capital (ROIC)
13.54%14.54%10.39%13.21%10.69%14.11%
Return on Capital Employed (ROCE)
22.30%22.30%18.50%16.90%16.10%21.70%
Earnings Yield
9.30%11.02%16.04%15.14%17.76%11.74%
FCF Yield
-1.68%-2.00%-60.34%-40.48%-23.75%-1.28%
Dividend Yield
1.63%-3.62%3.19%4.40%6.24%
Payout Ratio
39.33%42.41%39.61%37.67%61.14%78.64%
Buyback Yield / Dilution
-8.91%-8.91%--50.00%--1.64%
Total Shareholder Return
-7.25%-8.91%3.62%-46.81%4.40%4.60%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.